Related Experiment Videos
Radiation-induced injury to the visual pathway
G L Jiang1, S L Tucker, R Guttenberger
1Department of Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Summary
Radiation therapy for nasal and paranasal sinus cancers can cause visual pathway injury. Total radiation dose is the primary factor determining the risk of optic neuropathy and chiasm injury, with doses under 50 Gy showing no such complications.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Oncology
Background:
- Radiation therapy is a common treatment for nasal cavity and paranasal sinus cancers.
- Visual pathway structures are at risk of injury from radiation treatment.
- Understanding dose-response relationships is crucial for minimizing radiation-induced visual impairment.
Purpose of the Study:
- To review radiation-induced injury to the visual pathway in patients treated for nasal cavity and paranasal sinus cancers.
- To identify factors influencing the incidence and latency of visual impairment.
- To establish dose thresholds for optic neuropathy and chiasm injury.
Main Methods:
- Retrospective cohort study of 219 patients treated between 1969 and 1985.
- Analysis of orbital shielding, treatment plans, and visual acuity follow-up.
- Utilized Cox proportional hazard model and Linear-Quadratic (LQ) model for failure-time data analysis.
Main Results:
- Corneal injury occurred in 24/49 patients treated without orbital shielding, influenced by dose and chemotherapy.
- Symptomatic retinopathy observed in 7/77 patients, with no correlating variables.
- Optic neuropathy (8 patients) and chiasm injury (11 patients) were dose-dependent, with no occurrences below 50 Gy.
Conclusions:
- Total radiation dose is the predominant determinant of visual pathway injury, including optic neuropathy and chiasm injury.
- A threshold of < 50 Gy appears protective against optic neuropathy and chiasm injury.
- Careful dose management and consideration of orbital shielding are essential in radiotherapy for head and neck cancers.